콜레스테롤 검사 서비스 시장 규모 : 검사 유형, 제품 유형, 용도, 연령층, 서비스 프로바이더별, 세계 예측(2024-2032년)

Cholesterol testing services market size is estimated to register 8.1% CAGR from 2024 to 2032 driven by the increasing prevalence of cardiovascular diseases (CVDs) and the growing health awareness among the population. As per WHO, CVDs are the world's leading cause of death, claiming approximately 17.9 million lives annually. As lifestyle-related conditions, such as obesity, diabetes, and high blood pressure have become common, individuals are more inclined to seek regular cholesterol screenings to manage their health proactively.

The development of more accurate, rapid, and user-friendly cholesterol testing methods is also enhancing the accessibility and convenience for patients, encouraging more frequent testing. The integration of cholesterol testing services into routine health check-ups and wellness programs, both in clinical settings and through home testing kits will also broaden their availability and appeal.

The market is classified into test type, product type, application, age group, service provider, and region.

Based on test type, the cholesterol testing services market from the triglyceride tests segment is anticipated to witness substantial growth through 2032. This is due to the strong need to provide crucial insights into the overall lipid profile, which is essential for comprehensive cardiovascular risk assessment. High triglyceride levels are often associated with increased risk of heart disease, stroke, and other metabolic disorders, making monitoring vital for preventive healthcare.

Cholesterol testing services industry from the hyperlipidemia application segment will generate notable revenue during 2024-2032 owing to the rising prevalence of hyperlipidemia. Managing hyperlipidemia requires regular monitoring of these lipid levels to prevent cardiovascular diseases and other associated health complications. As more individuals are diagnosed with hyperlipidemia, the demand for cholesterol testing services will also increase to facilitate early detection and ongoing management.

Asia Pacific cholesterol testing services market is slated to depict decent growth rate through 2032 backed by the increasing prevalence of cardiovascular diseases and lifestyle-related health issues. Rapid urbanization and changing dietary habits are contributing to higher cholesterol levels among the population, further necessitating regular cholesterol monitoring. Government initiatives and public health campaigns for promoting routine health screenings are also adding to the regional industry growth.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising prevalence of cardiovascular diseases
    • 3.2.1.2 Growing awareness of preventive healthcare
    • 3.2.1.3 Increasing geriatric population
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Regulatory and quality assurance challenges
    • 3.2.2.2 High cost associated with the testing services
• 3.3 Growth potential analysis
• 3.4 Technological landscape
• 3.5 Regulatory landscape
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive positioning matrix
• 4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Test Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Total cholesterol tests
• 5.3 High density lipoprotein (HDL) cholesterol tests
• 5.4 Low density lipoprotein (LDL) cholesterol tests
• 5.5 Triglyceride tests
• 5.6 Other tests

Chapter 6 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Testing kits
• 6.3 Testing strips
• 6.4 Other product types

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Cardiovascular diseases
• 7.3 Diabetes
• 7.4 Obesity
• 7.5 Hyperlipidemia
• 7.6 Other applications

Chapter 8 Market Estimates and Forecast, By Age Group, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Geriatric
• 8.3 Adult
• 8.4 Pediatric

Chapter 9 Market Estimates and Forecast, By Service Provider, 2021 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 Hospitals and clinics
• 9.3 Diagnostic laboratories
• 9.4 Ambulatory care centers
• 9.5 Other service providers

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 10.1 Key trends
• 10.2 North America
  • 10.2.1 U.S.
  • 10.2.2 Canada
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 France
  • 10.3.4 Spain
  • 10.3.5 Italy
  • 10.3.6 Netherlands
  • 10.3.7 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 Japan
  • 10.4.2 China
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 South Korea
  • 10.4.6 Rest of Asia Pacific
• 10.5 Latin America
  • 10.5.1 Brazil
  • 10.5.2 Mexico
  • 10.5.3 Argentina
  • 10.5.4 Rest of Latin America
• 10.6 Middle East and Africa
  • 10.6.1 Saudi Arabia
  • 10.6.2 South Africa
  • 10.6.3 UAE
  • 10.6.4 Rest of Middle East and Africa

Chapter 11 Company Profiles

• 11.1 Abbott Laboratories
• 11.2 Accu Reference Medical Lab, LLC
• 11.3 Atherotech Diagnostics Lab
• 11.4 Bio-Reference Laboratories, Inc.
• 11.5 Boston Heart Diagnostics Corporation
• 11.6 Cell Biolabs Inc.
• 11.7 Clinical Reference Laboratory, Inc.
• 11.8 Eurofins Scientific
• 11.9 Mayo Clinic Laboratories
• 11.10 Quest Diagnostics Incorporated
• 11.11 Randox Laboratories Limited
• 11.12 Sonic Healthcare Limited
• 11.13 SpectraCell Laboratories Inc.
• 11.14 SYNLAB Holding Deutschland GmbH
• 11.15 Thermo Fisher Scientific Inc.